🇺🇸 FDA
Patent

US 7973075

Kainate receptor-selective epimeric analogs of dysiherbaine

granted A61KA61K31/35

Quick answer

US patent 7973075 (Kainate receptor-selective epimeric analogs of dysiherbaine) held by Northwestern University expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/35